Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF AUGUST 18, 2023 SAM #7934
SOLICITATION NOTICE

66 -- BroadPharm lipids Brand Name

Notice Date
8/16/2023 3:47:24 PM
 
Notice Type
Combined Synopsis/Solicitation
 
Contracting Office
NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
 
ZIP Code
20892
 
Solicitation Number
RFQ-NIH-NIAID-2180801
 
Response Due
8/25/2023 12:00:00 PM
 
Archive Date
09/09/2023
 
Point of Contact
Margaret Schott, Phone: 4063759815
 
E-Mail Address
margaret.schott@nih.gov
(margaret.schott@nih.gov)
 
Description
This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 �Streamlined Procedures for Evaluation and solicitation for commercial Items,� as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIH-NIAID-2180801and the solicitation is issued as a Request for Quotes (RFQ). This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2023-04 June 02, 2023. The North American Industry Classification System (NAICS) code for this procurement is 325414 - Biological Product (except Diagnostic) Manufacturing. The requirement is being competed with a brand name restriction, and without a small business set-aside. The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for the following Brand Name Supplies: Catalog No Product Name� Quantity BP-25498 ALC-0315 1x50mg BP-25499 SM-102 1x50mg BP-26359 BP Lipid 101 1x50mg BP-26360 BP Lipid 102 1x50mg BP-26361 BP Lipid 103 1x50mg BP-26362 BP Lipid 104 1x50mg BP-26363 BP Lipid 105 1x50mg BP-26364 BP Lipid 106 1x50mg BP-26365 BP Lipid 107 1x50mg BP-26367 BP Lipid 109 1x50mg BP-26370 BP Lipid 112 1x50mg BP-26371 BP Lipid 113 1x50mg BP-26372 BP Lipid 114 1x50mg BP-26373 BP Lipid 116 1x50mg BP-26374 BP Lipid 117 1x50mg BP-26375 BP Lipid 118 1x50mg BP-26377 BP Lipid 120 1x50mg BP-26379 BP Lipid 122 1x50mg BP-26380 BP Lipid 123 1x50mg BP-26381 BP Lipid 124 1x50mg BP-26383 BP Lipid 126 1x50mg BP-26466 BP Lipid 209 1x50mg BP-26468 BP Lipid 211 1x50mg BP-26469 BP Lipid 212 1x50mg BP-26471 BP Lipid 214 1x50mg BP-26485 BP Lipid 128 1x50mg BP-26386 BP Lipid 129 1x50mg BP-26388 BP Lipid 131 1x50mg BP-26390 BP Lipid 133 1x50mg BP-26392 BP Lipid 135 1x50mg BP-26393 BP Lipid 136 1x50mg BP-26395 BP Lipid 138 1x50mg BP-26397 BP Lipid 140 1x50mg BP-26399 BP Lipid 142 1x50mg BP-26403 BP Lipid 146 1x50mg BP-26408 BP Lipid 151 1x50mg BP-27892 BP Lipid 226 1x50mg BP-27893 BP Lipid 216 1x50mg BP-27894 BP Lipid 217 1x50mg BP-27895 BP Lipid 218 1x50mg BP-27896 BP Lipid 219 1x50mg BP-27897 BP Lipid 220 1x50mg BP-27898 BP Lipid 221 1x50mg BP-27899 BP Lipid 222 1x50mg BP-27900 BP Lipid 223 1x50mg BP-27901 BP Lipid 224 1x50mg BP-27902 BP Lipid 225 1x50mg �BP-26368 BP Lipid 110 1x50mg BP-26369 BP Lipid 111 1x50mg BP-26378 BP Lipid 121 1x50mg BP-26382 BP Lipid 125 1x50mg BP-26384 BP Lipid 127 1x50mg BP-26467 BP Lipid 210 1x50mg BP-26470 BP Lipid 213 1x50mg BP-26387 BP Lipid 130 1x50mg BP-26389 BP Lipid 132 1x50mg BP-26391 BP Lipid 134 1x50mg BP-26394 BP Lipid 137 1x50mg BP-26396 BP Lipid 139 1x50mg BP-26398 BP Lipid 141 1x50mg BP-26400 BP Lipid 143 1x50mg BP-26401 BP Lipid 144 1x50mg BP-26402 BP Lipid 145 1x50mg BP-26404 BP Lipid 147 1x50mg BP-26405 BP Lipid 148 1x50mg BP-26406 BP Lipid 149 1x50mg BP-26407 BP Lipid 150 1x50mg BP-26409 BP Lipid 152 1x50mg BP-26410 BP Lipid 153 1x50mg BP-26411 BP Lipid 154 1x50mg Place of Performance: NIH, 9 West Watkins Mill Road, Gaithersburg, MD 20878, United States.� FOB: Destination The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein.� The award will be based on the following: technical capability to meet the requirements and price. The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (MAR 2023) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (DEC 2022) FAR 52.204-7 System for Award Management (OCT 2018) (Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements � Representation (JAN 2017) FAR 52.204�26 Covered Telecommunications Equipment or Services-Representation (OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26 The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (DEC 2022) FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (JUN 2023) *The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting. FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023) FAR 52.204-13 System for Award Management Maintenance (OCT 2018) FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (DEC 2015) 52.252-2 -- Clauses Incorporated by Reference. (FEB 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address:� http://farsite.hill.af.mil/vffara.htm By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax. Offers may be e-mailed to Margaret Schott (E-Mail/ margaret.schott@nih.gov). Offers shall include RFQ number in the subject line (RFQ-NIH-NIAID-2180801). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) All responsible sources may submit an offer that will be considered by this Agency.� Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Margaret Schott.
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/af316ad3bb4f400a9a1498220d4ec629/view)
 
Place of Performance
Address: Gaithersburg, MD 20878, USA
Zip Code: 20878
Country: USA
 
Record
SN06793564-F 20230818/230817085754 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.